Description: This session will present results of the most recent SOA/LIMRA studies of variable and fixed-indexed annuity policyholder behavior including withdrawal behavior, guaranteed living benefit elections and surrender activity. Conducted annually since 2006, a discussion on the results of these studies show how they have changed over time, as well as areas where the analysis will need to change or expand. After that, the presenters will focus on dynamic lapse for hot money businesses, which is an important topic for fixed deferred annuity. Key takeaways from this area will include an understanding how to differentiate between hot money and warm money, the different formulas used in the industry, and how to adjust an asset portfolio to protect against the risks associated with hot money businesses.

Description: In the modern world, users expect a top-notch user experience on whatever device they are using. Marketing, distribution, and user experience have become the trinity in finding, acquiring, and keeping a user through the end of an application process. Recently, particularly in the post-COVID digital-first world, many insurance companies have transformed their technology teams to build significantly improved user-experiences on their websites and mobile apps. The designs are often limited by the insurance products that the consumer wants to interact with (and how they want to interact). In this session, the presenters will look at how actuaries can design the insurance product simultaneously to the user experience, and let the experience drive product development.

Description: The emergence of technology to advance data visualization has helped uncover hidden insights in our data that was previously difficult to do. Designing engaging charts and crafting gripping stories through visualization has never been easier. This session will focus on understanding the fundamentals and considerations when deploying data visualization and selecting the best data visualization tool. Additionally, the course will provide an example of creating advanced data visualizations using Power BI.

Description: With the COVID-19 pandemic racing through the world, SOA researchers have created an insightful analysis of the current situation. Hear how actuaries have been able to provide near real- time insights into the pandemic and its impact on society.

Description: "Hear an overview of recent results and potential scenarios that may impact the future of the ACA market. Review recent reported industry level profitability before transitioning to a discussion of how current market dynamics may influence the future profitability of this segment. Results from microsimulation economic models will be presented to help illuminate market shifts. Issues that will be explored include how ICRA availability might influence individual decision making, as well as how a move to level funding is impacting the small group market. By attending this session, you will: Understand the recent average and variation of industry performance in the ACA market segment. Describe current policy and market forces that are expected to impact this segment. Explain the range of market scenarios that may result due to these forces."

Description: Risk is opportunity! Equipped with skills to analyze risks, actuaries are no longer limited to applying these skills solely within traditional actuarial roles. Listen in as the presenters share their career experience in a non-traditional role and provide insights on how being an actuary can bring additional value to the profession.

Description: In this session, presenters will share the impacts of transition to IFRS 17 on equity and various KPIs across insurance companies (Life & P&C), as well as share some observations of what the IFRS 17 landscape looks like across different global regions. The session will conclude with lessons learned and expectations for emerging practices under IFRS 17 globally.

Description: Defining fairness for life insurance processes is complex and challenging as well as subjective. This webcast will be a discussion of the challenges and opportunities presented as our profession rethinks fairness in the context of processes involved in developing and managing life insurance, especially risk classification.

Description: In this session, you will learn about key cost drivers in pharmacy trends, including but not limited to: New high-cost drugs, including gene therapies, that treat rare and/or expensive conditions such as spinal muscular atrophy (SMA), inherited retinal disease, hemophilia A and B, Duchenne muscular dystrophy (DMD), sickle cell anemia and cerebral adrenoleukodystrophy (CALD) Other cost drivers in the prescription drug category, including the emergence of GLP-1s, digital therapeutics, targeted immunomodulators, accelerated approval drugs and expanded indications The implications of the end of the COVID-19 Public Health Emergency (PHE) on the costs of COVID-19 vaccines, testing and treatment claims Downward influences on pharmacy costs, such as the availability of new generic drugs and biosimilars Emerging trends in pharmacy benefits manager (PBM) contracting, the initial portion of this discussion will be led by a pharmacist and former state pharmacy director.

Description: After three decades of relatively stable overall inflation trends, the United States has seen significant increases over the last twelve months. What could this mean for inflation in the medical sector? Explore past patterns between the two phenomena, and what drivers stakeholders can monitor to be best aware of what could be coming.